Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.
NEW YORK — WPP Group’s Ogilvy & Mather has been given the creative assignment for Schering-Plough’s over-the-counter version of Claritin, its widely successful allergy relief drug.
Clarinex was launched in January, as Kenilworth, N.J.-based Schering-Plough sought to head off generic competition to prescription-only Claritin. It is expected to be available in over-the-counter form before the end of this year, a Schering-Plough representative said. The $80 million in advertising for Claritin is created by WPP’s CommonHealth Quantum Group, Parsippany, N.J.
Schering-Plough
WORK SMARTER - LEARN, GROW AND BE INSPIRED.
Subscribe today!
To Read the Full Story Become an Adweek+ Subscriber
Already a member? Sign in